Registration is now open for the ASH Foundation Run/Walk! 👟 Start your Sunday at #ASH26 with a 3K or 5K in New Orleans, or participate virtually from anywhere. Proceeds from every registration support the #Fight4Hematology. Register now: https://ow.ly/LiU250ZnW7Q #Fight4Hematology

Congratulations to the first graduating cohort of the ASH HFFTP! 🎉 After three years of growth, mentorship, and collaboration, these fellows have reached an incredible milestone in their careers. Learn more about the program: https://ow.ly/rBRZ50Znt4A #ASHTrainee

The ASH Committee on Communications just finished a productive Summer 2026 meeting! Members discussed the continued work of #Fight4Hematology and more. Thanks to all committee members for their dedication to advancing the field. #Hematology

⏰ Reminder: 2027 ASH Honorific Awards nominations are open! If you know someone who has made a lasting impact in hematology through research, mentorship, or quality care, nominate them for one of these prestigious awards. 🔗 https://ow.ly/sx8s50ZmYMF #ASHAwards #HemeSky #MedSky

ASH continues to engage with CMS on policies that impact patient access to care, supporting efforts to modernize prior authorization, increase transparency, and reduce administrative burden. Read the letter: https://ow.ly/cHLI50ZmJ91

The Office of Management and Budget has proposed changes to the federal grant-making process that could affect hematology research, scientific dissemination, & patient care. Read ASH's full statement: https://ow.ly/pvP350ZmoSQ #Fight4Hematology

There’s still time to submit your abstract for #ASH26. Present your research on hematology’s biggest stage at the 68th ASH Annual Meeting and Exposition. 📅 Submit by August 4, 2026 🔗 https://ow.ly/v6QA50Zeb3Z #HemeSky #OncSky

📖 Prepare for boards. Refresh your expertise. The ASH Hematology Review Series provides expert-led reviews of essential topics in classical and malignant hematology. Enroll today: https://ow.ly/LaGO50ZbU1S #ABIM #Hematology #HemeSky #MedEd #MedSky #BoardExamsPrep

ASH, alongside partners, is raising the visibility of the critical role the CDC’s Division of Blood Disorders and Public Health Genomics plays in providing the technical expertise, data, and public health leadership across hematology. https://ow.ly/khEG50ZhmTV

Reminder: ASH is now accepting public comments on draft recommendations for the Treatment of AL Amyloidosis. Submit your comments by July 7, 2026: https://ow.ly/Oqc950ZhgwV #Hematology #MedSky #HemeSky

Finding specialized talent in #hematology starts with reaching the right community. The ASH Job Center helps employers showcase open roles to qualified hematology and hematology-oncology professionals. Post your opening today: https://ow.ly/1ZN550YR8Iz #Jobsearch #MedSky #HemeSky

A new study of the bispecific antibody (BsAb) epcoritamab for the treatment of Richter transformation highlights the difficulty of managing patients with this disease, as well as the potential impacts of prior therapy on long-term outcomes. Read more: https://ow.ly/gnyF50ZfNb8

Trying to make sense of how clinical trials actually work? Start here. The new ASH Clinical Trial Map outlines the trial process, from idea to real-world implementation. Explore now: https://ow.ly/aY4o50ZfmvY

A proposed rule from the Office of Management and Budget would reshape the federal grantmaking process and threaten research, public health, & innovation. ASH is preparing formal comments. Learn more: https://ow.ly/rW8N50ZgqlC #Fight4Hematology #HemeSky #MedSky #ResearchSavesLives

🌍 Still time to apply to the ASH International Outreach Initiative. Eligible hospitals, universities, and clinics in low- and middle-income countries can receive free hematology education resources, including the ASH SAP and Annual Meeting webcasts. https://ow.ly/R1G350Z2MzN #HemeSky

One platform. Endless genomic insights. 🧬 ASHOP gives researchers & clinicians access to comprehensive genomic data to help uncover therapeutic targets, investigate clinical correlations, & advance discovery across blood diseases. Learn more: https://ow.ly/Ww3g50ZfSzG #Hematology

ASH is proud to honor 11 distinguished hematologists with its most prestigious awards and named lectures, recognizing transformative contributions that have advanced research, patient care, and education in blood diseases. 🔗https://ow.ly/3Sue50ZfSjI #Hematology #ASHAwards

🚨 Last chance: ASH CRTI applications close soon! Fellows & early- to mid-career #hematology faculty in Latin America, Asia-Pacific, and the MMENA apply now for in-person training in clinical trial design, research, mentorship & leadership: https://ow.ly/IjP650ZfmgC #ASHTrainee

ASH continues to engage with NIH on its FY27–FY31 Strategic Plan, highlighting key priorities from the ASH Agenda for Hematology Research to help shape the agency’s future research direction. Read the request: https://ow.ly/P8Vv50Zeq06 #Fight4Hematology #ResearchSavesLives

Your research can inform, inspire, and ignite progress in #hematology! The abstract submission portal for the 68th ASH Annual Meeting and Exposition is OPEN. Share your advancements in science, translational research, or care disparities. Submit today: https://ow.ly/z80i50ZebYA #ASH26

You can make a difference for people living with sickle cell disease. The ASH Foundation’s Sickle Cell Disease Initiative Fund supports research, education, advocacy, and programs like CONSA. Start your fundraiser today: https://ow.ly/mCY650ZcP9p #ConquerSCD #HemeSky #MedSky

This Tuesday, join the Journal Club webinar to explore the cellular pathways involved in hemoglobin uptake and processing in SCD and potential therapeutic implications. https://ow.ly/K9GO50Z9w2e #HemeSky #ConquerSCD Blood Journals Portfolio

Donations to the ASH Foundation have helped advance SCD awareness, education, and care. Support the future of sickle cell care by donating to the ASH Sickle Cell Disease Initiative Fund: give.hematology.org/SCD #WorldSickleCellDay #ConquerSCD #Hematology

Nearly 80% of SCD cases occur in sub-Saharan Africa, where access to screening & lifesaving interventions remains limited. ASH’s Consortium on Newborn Screening in Africa (CONSA) has supported newborn screening in 7 countries across sub-Saharan Africa. www.hematology.org/g...

Today is World Sickle Cell Disease Day (SCD). SCD is the world's most common inherited blood disorder, affecting an estimated 7.75 million people globally and 515,000 newborns each year.

🩸At the 2026 CONSA Laboratory Summit, 35+ participants shared best practices in newborn screening, explored new technologies, & strengthened SCD diagnostic capacity across Africa. Support CONSA through the ASH Foundation: https://ow.ly/UOo150ZcNMi #ConquerSCD #HemeSky #MedSky

Want to help highlight the next wave of hematology research? Organize a virtual or in-person ASH Poster Walk at the 68th ASH Annual Meeting and Exposition and showcase emerging science on a global stage. Apply today: https://ow.ly/LAIj50ZcjYH #HemeSky #HemeOnc

In this episode of The Hematologist podcast, Contributing Editor Tycel Phillips, MD, speaks with Arnon Kater, MD about the emerging role of bispecific antibodies in the treatment of Richter transformation. Listen now: https://ow.ly/OV4k50Z9x2G #Hematology

Clinical trials that reflect the lived experiences of patients lead to better care. The ASH Toolkit for Clinical Trial Sponsors outlines strategies to improve access and representation. View the toolkit: https://ow.ly/rgtg50YMPhw #HemeSky #ClinicalTrials

The 2026 ASH Hematology Review Series (HRS) is here! Built to ease the stress of board exams, HRS provides expert lectures and live sessions from June 6 to October 15. Enroll today: https://ow.ly/bWfZ50ZbOP4 #ABIM #Hematology #HemeSky #MedSky